Editor's Note Erin Fox, senior pharmacy director at University of Utah Health who has been monitoring drug shortages for over 20 years, spoke to AP News in June of her concerns. Currently, the situation is worse than ever, with total active shortages hitting an all-time high of 323 (with 48…

Read More

Editor's Note As outpatient surgery continues to gain popularity and the need to cut costs persists, Becker’s ASC Review sat down with Jim Freund, managing partner for Physician Transaction Advisors, to discuss the below three key trends in the ambulatory surgery center (ASC) industry, per Becker’s July 18 article. Number…

Read More

Editor's Note New findings highlight an urgent need to improve preventive measures against animal-borne diseases jumping to humans and potentially causing another global pandemic, US Today reported on July 21. The article details a study from  Harvard Law School and New York University that examined animal-human interactions in 15 countries,…

Read More

Editor's Note:  Problems with Philips’ BiPap V30, BiPAP A30, BiPAP A40 ventilators resulted in only 7 recorded deaths and 10 injuries—far fewer than the 65 deaths and 952 injuries initially reported by the US Food and Drug Administration (FDA). In a July 10 update to the class 1 recall—the most…

Read More

Editor's Note New findings from health consultant Sg2’s 2024 Impact of Change report projects a 21% increase in ambulatory surgery center (ASC) volume, to reach 44 million by 2034, ASC Focus July 8 reports. An aging population, better diagnostics, and epidemiological factors are driving this demand, Tori Richie, senior consulting…

Read More

Editor's Note Introduced by a bipartisan group of Senators, the Healthcare Cybersecurity Act aims to bolster the cyber-defenses of healthcare entities through the collaboration of the U.S. Department of Health and Human Services (HHS) and the Cybersecurity and Infrastructure Security Agency (CISA). According to a July 16 report in HealthExec,…

Read More

Editor's Note The US Food & Drug Administration has designated recalls of Baxter’s Life2000 Ventilator and the I-Pack Injection Kit from Bausch + Lomb and subsidiary Synergetics Inc. as Class 1, the most severe category indicating serious risk of injury or death. According to FDA’s July 15 announcement, the ventilator…

Read More

Editor's Note As the Republican National Convention meets in Milwaukee to nominate Donald Trump, the party is not expected to unveil a detailed healthcare platform. However, a July 15 report in Modern Healthcare covers what plans and past records reveal about the potential direction of health policy under a GOP…

Read More

Editor's Note The US Food and Drug Administration (FDA) has classified recalls by Hamilton Medical and Megadyne as Class 1 events, the most severe category indicating risk of serious injury or death. According to the agency’s July 11 report, Hamilton Medical is correcting software for its HAMILTON-C6 Medical Ventilator to…

Read More

Editor's Note Hospital groups are criticizing CMS' proposed 2.6% pay increase for 2025, deeming it insufficient for nonprofit hospitals with operating margins near or below zero, according to a July 11 article in Becker’s Hospital CFO Report. The American Hospital Association and America's Essential Hospitals argue the rise won't cover…

Read More